doi: 10.1016/S0140-6736(15)00803-X 202 NewsomePNBuchholtzKCusiKLinderMOkanoueTRatziuVet al
As prescribing continues to rise, awareness of GLP-1 dermatologic effects ensures safer therapy and more confident patient counseling
Dehydration is a related concern, as both reduced fluid intake (due to appetite suppression) and increased fluid losses (from gastrointestinal side effects) can contribute to volume depletion
Patients with chronic kidney disease should not initiate magnesium supplementation without medical supervision, as impaired renal excretion increases the risk of hypermagnesemia
In the United States, one in eight adults say theyve tried one of these medications, which are known as GLP-1 drugs, and that number seems sure to rise as prices fall and new oral formulations hit the market
Who can use GLP-1 drugs for weight loss